Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis. - Hashimoto, Teppei; Yoshida, Kohsuke; Yokoyama, Yuichi; Hashimoto, Naonori; Kaneshiro, Kenta; Yoshikawa, Takahiro; Tateishi, Koji; Terashima, Yasuhiro; Matsui, Kiyoshi; Hashiramoto, Akira (Clinical & Experimental Immunology, 2023)